10.56
-0.16(-1.49%)
Currency In USD
| Previous Close | 10.72 |
| Open | 10.31 |
| Day High | 10.69 |
| Day Low | 10.15 |
| 52-Week High | 18.67 |
| 52-Week Low | 3.97 |
| Volume | 1.89M |
| Average Volume | 1.62M |
| Market Cap | 975.74M |
| PE | -0.93 |
| EPS | -11.35 |
| Moving Average 50 Days | 15.24 |
| Moving Average 200 Days | 10.08 |
| Change | -0.16 |
If you invested $1000 in Fortrea Holdings Inc. (FTRE) since IPO date, it would be worth $330 as of March 03, 2026 at a share price of $10.56. Whereas If you bought $1000 worth of Fortrea Holdings Inc. (FTRE) shares 2 years ago, it would be worth $287.74 as of March 03, 2026 at a share price of $10.56.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Fortrea Expands Executive Team, Appointing Oren Cohen as Chief Medical Officer and Scott Dove as President of Clinical Pharmacology Services
GlobeNewswire Inc.
Feb 17, 2026 12:00 PM GMT
Adds to executive focus on early clinical development and deepens medical and scientific partnership with clientsDURHAM, N.C., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization
Fortrea Announces Date for Fourth Quarter and Full Year 2025 Financial Results and Conference Call
GlobeNewswire Inc.
Jan 29, 2026 1:08 PM GMT
DURHAM, N.C., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its fourth quarter and full year 2025 financial results before the m
Fortrea Announces Updated Presentation Time at Upcoming J.P. Morgan Healthcare Conference
GlobeNewswire Inc.
Jan 09, 2026 4:24 PM GMT
DURHAM, N.C., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced an updated presentation time of 11:15 am PST on Tuesday, January 13, 2026, at the J.P. Morgan Annual Heal